News

OnePiece Labs Unveils New Accelerator for Web3 Innovators

OnePiece Labs Unveils New Accelerator for Web3 Innovators

OnePiece Labs Unveils New Cohort for Web3 Innovators

OnePiece Labs has officially launched its latest cohort, showcasing an elite group of Web3 innovators dedicated to building on the Solana blockchain. The initiative focuses on fostering an environment where these teams can craft a powerful ecosystem filled with high-performance decentralized applications (dApps) and foundational infrastructure that challenge the norms of decentralized technology.

In a dynamic ten-week journey, these founders will engage in product refinement and community development, all while gaining visibility within the growing Solana ecosystem. OnePiece Labs is committed to providing extensive support through its hands-on methodology, further enhanced by Solana's robust, scalable blockchain architecture. The firm expresses its gratitude towards the global network of Solana Superteams for their ongoing contributions in identifying and promoting talented developers from various regions.

The Fusion of Solana’s Capabilities and Founder Aspirations

As the demand for decentralized applications soars, Solana has solidified its stature as the prime blockchain for performance-driven solutions. The platform recently witnessed remarkable activity, particularly with over $250 million in USDC minted within a week, highlighting the growing interest in cost-effective and high-speed DeFi execution capabilities. Innovations such as DOLAI, an AI-enabled stablecoin, also demonstrate Solana's adaptability to emerging technologies, paving the way for more interoperable and finance-agent-based solutions.

These advancements establish Solana as the perfect foundation for the latest cohort of innovators focusing on real-world asset (RWA) tokenization, advanced PayFi infrastructure, and AI-enhanced tools. With features such as quick settlement and composability, Solana equips founders with the essential tools to develop impactful Web3 products, and OnePiece Labs is determined to accelerate their paths to success.

Introducing the New Cohort

The newly formed cohort comprises a diverse array of ambitious builders engaged in various forward-thinking Web3 sectors. Each participant brings unique technical expertise and a pronounced desire to expand on the Solana platform:

AquaFlux

AquaFlux is pioneering a decentralized finance (DeFi) protocol that dissects real-world assets into three distinct tokens: Principal, Coupon, and Shield. Led by founder Yole Yu, AquaFlux stands as the first DeFi-centric structured RWA protocol, transforming real-world assets into programmable, composable tranches that accommodate risk-adjusted yield strategies and secondary market liquidity.

Codigo

Under the leadership of JP Marcos, Codigo offers an end-to-end DevAI platform that elevates the Solana developer experience, taking them from concept to Mainnet seamlessly. The platform enables teams to create production-ready smart contracts and front-ends with minimal input, amplifying productivity while ensuring robust security.

DNAi

Founded by Xiao Shu, DNAi aims to assemble the first decentralized AI-powered health data platform. This innovative venture seeks to turn personal genomic and BioWearable data into secure, verifiable digital assets, empowering users to monetize their data while contributing to biomedical research.

Homo Memetus

With founder Danbee No at the helm, Homo Memetus is creating the first agent capital market where AI trading agents compete and evolve, transforming their performance into tokenized, revenue-sharing ventures.

Intelligence Cubed

Led by Fernando Jia, Intelligence Cubed is on a mission to build a decentralized marketplace for AI, minting AI models as assets that can be traded in real-time, creating a new paradigm of value in the AI domain.

MicroBonk

MicroBonk, under founder Rony Cai, focuses on converting meme hype into on-chain reserves, laying down the financial structure for the Bonk ecosystem.

Nomyx

Ubair Javaid’s project Nomyx simplifies the digital asset landscape, helping asset managers transition assets to on-chain ecosystems while maintaining compliance and rapid deployment capabilities.

Puffy.AI

This project seeks to redefine the process of quitting nicotine, utilizing a gamified approach powered by Solana, ensuring user engagement and support throughout their journey.

Spout

Founded by Marc Ryan, Spout is dedicated to introducing corporate bonds and equities on-chain, promoting compliance, privacy, and integration with DeFi mechanisms.

TruEstate

Chien-Jung Chiang's TruEstate enables global investors to access tokenized, compliant ownership of Japanese real estate, facilitating a gateway to high-quality investments.

WagerVS

Lance Durand’s WagerVS introduces a unique prediction and sweepstakes platform designed to revolutionize Web3 betting with community-driven dynamics.

Looking Ahead

As this cohort progresses, they will engage in strategic programming and form vital connections within the industry, all while showcasing their innovations across a variety of platforms. Their projects will feature prominently in discussions shaping the future of decentralized technologies, with opportunities for live demonstrations and broader industry engagement.

About OnePiece Labs

Located in Silicon Valley, OnePiece Labs is a founder-centric accelerator devoted to nurturing early-stage Web3 startups from conception to worldwide success. With a vast network exceeding 100,000 community members and over 80 portfolio companies, the accelerator has raised more than $60 million for its founders. OnePiece Labs equips visionary teams with essential education, mentorship, and market entry resources, conducting thematic batches in collaboration with leading Layer 1 ecosystems and investment networks.

Stay Connected:

Website: https://www.onepiecelabs.xyz
Telegram: https://t.me/onepiecelabs
Twitter: https://twitter.com/OnePieceLabs
Newsletter: https://substack.com/@oplabs
Discord: https://discord.com/invite/7J8mubgjCu

Contact:
Dafu Gao
media@onepiecelabs.xyz

Frequently Asked Questions

What is OnePiece Labs?

OnePiece Labs is an accelerator based in Silicon Valley that supports early-stage Web3 startups, providing them with crucial resources to grow and succeed.

What blockchain is the new cohort focusing on?

The new cohort is focusing on developing applications on the Solana blockchain.

What kind of projects are included in the cohort?

The cohort includes projects that range from DeFi protocols to AI health platforms, all aiming to innovate within the Web3 space.

How long is the OnePiece Labs cohort program?

The cohort program spans about ten weeks, during which participants refine their products and build community.

What resources does OnePiece Labs offer participants?

OnePiece Labs provides education, mentorship, and access to a wide network of industry professionals and investors to help startups flourish.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading